UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$767M |
| 2 |
Amazon
AMZN
|
+$288M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$287M |
| 4 |
NVIDIA
NVDA
|
+$259M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$347M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$316M |
| 3 |
Citigroup
C
|
+$269M |
| 4 |
Charter Communications
CHTR
|
+$229M |
| 5 |
NetEase
NTES
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.35% |
| 2 | Consumer Discretionary | 13.14% |
| 3 | Financials | 12.19% |
| 4 | Healthcare | 12.04% |
| 5 | Communication Services | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXK
2226
Endeavour Silver
EXK
$2.24B
| $648K | ﹤0.01% |
130,991
-49,100
| -27% | -$263K |
|
2227
Protagonist Therapeutics
PTGX
$8.55B
| $648K | ﹤0.01% |
25,000
+12,800
| +105% | +$324K |
|
2228
MGP Ingredients
MGPI
$403M
| $647K | ﹤0.01% |
10,943
| – | – |
|
2229
First Financial Corp
THFF
$948M
| $647K | ﹤0.01% |
14,365
| – | – |
|
|
BRSP
2230
BrightSpire Capital
BRSP
$651M
| $644K | ﹤0.01% |
75,606
-12,077
| -14% | -$103K |
|
|
VXRT
2231
DELISTED
Vaxart
VXRT
| $642K | ﹤0.01% |
106,102
+3,302
| +3% | +$25.4K |
|
|
PENG
2232
Penguin Solutions Inc
PENG
$2.24B
| $641K | ﹤0.01% |
27,864
+14,898
| +115% | +$323K |
|
|
MRSN
2233
DELISTED
Mersana Therapeutics
MRSN
| $640K | ﹤0.01% |
1,583
-1,144
| -42% | -$555K |
|
2234
CarParts.com
PRTS
$42.6M
| $634K | ﹤0.01% |
4,440
-580
| -12% | -$93.8K |
|
2235
Viking Therapeutics
VKTX
$3.88B
| $634K | ﹤0.01% |
100,240
-28,400
| -22% | -$200K |
|
|
EGIO
2236
DELISTED
Edgio, Inc. Common Stock
EGIO
| $631K | ﹤0.01% |
4,421
| – | – |
|
|
CLDT
2237
Chatham Lodging
CLDT
$632M
| $630K | ﹤0.01% |
47,860
| – | – |
|
2238
Compugen
CGEN
$212M
| $628K | ﹤0.01% |
73,150
| – | – |
|
2239
Waterstone Financial
WSBF
$371M
| $627K | ﹤0.01% |
30,690
-3,384
| -10% | -$66.9K |
|
2240
OneSpaWorld
OSW
$2.64B
| $626K | ﹤0.01% |
58,802
+5,902
| +11% | +$59.6K |
|
2241
Innoviva
INVA
$1.6B
| $622K | ﹤0.01% |
52,087
-37,935
| -42% | -$459K |
|
|
SA
2242
Seabridge Gold
SA
$2.72B
| $620K | ﹤0.01% |
38,371
+1,800
| +5% | +$33.5K |
|
2243
Vanda Pharmaceuticals
VNDA
$304M
| $620K | ﹤0.01% |
41,259
-6,591
| -14% | -$107K |
|
2244
Precigen
PGEN
$1.94B
| $619K | ﹤0.01% |
89,831
+13,000
| +17% | +$110K |
|
|
CNR
2245
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $618K | ﹤0.01% |
44,055
-8,700
| -16% | -$105K |
|
2246
Banc of California
BANC
$2.87B
| $617K | ﹤0.01% |
34,110
-7,591
| -18% | -$141K |
|
|
SPPI
2247
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $616K | ﹤0.01% |
188,936
+40,864
| +28% | +$146K |
|
2248
Great Southern Bancorp
GSBC
$878M
| $615K | ﹤0.01% |
10,854
+3,924
| +57% | +$210K |
|
|
CBB
2249
DELISTED
Cincinnati Bell Inc.
CBB
| $614K | ﹤0.01% |
40,023
+3,782
| +10% | +$57.9K |
|
2250
Argan
AGX
$6.9B
| $614K | ﹤0.01% |
11,509
| – | – |
|
Similar funds
UBS AM's Q1 2021 Portfolio in Review
As of Q1 2021, UBS AM held 2,645 positions worth $226B, up 6% from $213B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 4.9%. UBS AM opened 86 new positions and exited 44, leaving the 2,645-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Financials.
- UBS AM's largest Q1 2021 buy was Seagen Inc. Common Stock: 966,114 shares worth $134M.
- UBS AM added most to Infosys in Q1 2021, an estimated $767M increase.
- UBS AM's biggest Q1 2021 reduction was Alibaba, cutting an estimated $347M.
- UBS AM fully exited Lumen in Q1 2021, selling an estimated $45.5M.
- UBS AM's ten largest holdings make up 22% of its $226B portfolio in Q1 2021.
- UBS AM opened 86 new positions and closed 44 in Q1 2021.
- UBS AM's portfolio value rose 6% quarter-over-quarter to $226B.
Based on UBS AM's 13F filing for Q1 2021, filed 14 May 2021.